Assignee
ABIOGEN PHARMA SPA
IT·15 granted patents·13 pending applications·90 citations·filing 1996–2023
Top patents by PatentIndex Score
28 records- 0185US12083133B2Use of cholecalciferol as adjuvant in the treatment of muscular dystrophiesABIOGEN PHARMA SPA·Filed 2022·Granted Sep 10, 2024·1 cites·9 claims
- 0282US6387674B1Catalytic monoclonal antibodies with protease activity for selective lysis of protein component of plaques aggregates pathological conditionsABIOGEN PHARMA SPA·Filed 1998·Granted May 14, 2002·60 cites·11 claims
- 0373US2020147126A1Pharmaceutical formulation for the treatment of osteoarthritis containing clodronic acid and hyaluronic acidABIOGEN PHARMA SPA·Filed 2019·Application pending·0 cites
- 0472US2023233585A1Use of neridronic acid or of its salt for the treatment of osteoarthrosisABIOGEN PHARMA SPA·Filed 2023·Application pending·0 cites
- 0568US7077297B1Method for preparation of biocides mixed with carbon dioxide in a pressurized containerABIOGEN PHARMA SPA·Filed 2000·Granted Jul 18, 2006·17 cites·7 claims
- 0667US11123354B2Method for the treatment of osteoarthritisABIOGEN PHARMA SPA·Filed 2017·Granted Sep 21, 2021·1 cites·23 claims
- 0766US2026083694A1Composition comprising l-leucine and fish oilABIOGEN PHARMA SPA·Filed 2023·Application pending·0 cites
- 0865US7872007B2Process for the preparation of 2-(4-hydroxy-3-morfolynil)-2-cyclohexenoneABIOGEN PHARMA SPA·Filed 2007·Granted Jan 18, 2011·1 cites·20 claims
- 0963US9943540B2Pharmaceutical formulation for the treatment of osteoarthritis containing clodronic acid and hyaluronic acidABIOGEN PHARMA SPA·Filed 2014·Granted Apr 17, 2018·0 cites·10 claims
- 1063US7968748B2Process for resolving racemic mixtures and a diastereoisomeric complex of a resolving agent and an enantiomer of interestABIOGEN PHARMA SPA·Filed 2007·Granted Jun 28, 2011·2 cites·22 claims
- 1157US2018185407A1Pharmaceutical formulation for the treatment of osteoarthritis containing clodronic acid and hyaluronic acidABIOGEN PHARMA SPA·Filed 2018·Application pending·0 cites
- 1254US10815257B2Polymorph of sodium neridronate and preparation process thereofABIOGEN PHARMA SPA·Filed 2019·Granted Oct 27, 2020·0 cites·20 claims
- 1348US2023082870A1Composition for calcium supplementationABIOGEN PHARMA SPA·Filed 2022·Application pending·0 cites
- 1448US2022273676A1Cholecalciferol for use in the treatment of celiac diseaseABIOGEN PHARMA SPA·Filed 2020·Application pending·0 cites
- 1547US11512104B2Process for the preparation of the polymorph F of sodium neridronateABIOGEN PHARMA SPA·Filed 2020·Granted Nov 29, 2022·0 cites·16 claims
- 1647US6761289B1Preparation and metering of components mixed with Co2ABIOGEN PHARMA SPA·Filed 2000·Granted Jul 13, 2004·4 cites·10 claims
- 1743US11058138B2Composition for calcium supplementationABIOGEN PHARMA SPA·Filed 2018·Granted Jul 13, 2021·0 cites·33 claims
- 1843US2010069450A1Salt of 3-benzyl-2-methyl-2,3,3a,4,5,6,7, 7a- octahydrobenzo[d]isoxazol-4-oneABIOGEN PHARMA SPA·Filed 2007·Application pending·0 cites
- 1943US2017209470A1Use of neridronic acid or of its salt for the treatment of osteoarthrosisABIOGEN PHARMA SPA·Filed 2015·Application pending·0 cites
- 2043US2011039901A1PROCESS FOR PREPARING A CRYSTALLINE FORM COMPOUND OF 3-BENZYL-2-METHYL-2,3,3a,4,5,6,7,7a-OCTAHYDROBENZO[d]ISOXAZOL-4-ONEABIOGEN PHARMA SPA·Filed 2009·Application pending·0 cites
- 2143US2010069451A1Salt of 3-benzyl-2-methyl-2,3,3a,4,5,6,7, 7a- octahydrobenzo[d]isoxazol-4-oneABIOGEN PHARMA SPA·Filed 2007·Application pending·0 cites
- 2240US2020155478A1Xibornol for use in the treatment of acne vulgarisABIOGEN PHARMA SPA·Filed 2018·Application pending·0 cites
- 2340US2011039902A1PROCESS FOR PREPARING A CRYSTALLINE FORM COMPOUND OF 3-BENZYL-2-METHYL-2,3,3a,4,5,6,7,7a-OCTAHYDROBENZO[d]ISOXAZOL-4-ONEABIOGEN PHARMA SPA·Filed 2009·Application pending·0 cites
- 2439US10736856B2Use of xibornol as active agent in the treatment of viral infectionsABIOGEN PHARMA SPA·Filed 2017·Granted Aug 11, 2020·0 cites·18 claims
- 2537USRE37330EGlibenclamide-metformin combination for the treatment of diabetes mellitus of type IIABIOGEN PHARMA SPA·Filed 1996·Granted Aug 14, 2001·4 cites·7 claims
- 2634US7678571B2Procedure for the large-scale T-lymphocytes culture in a homogeneous systemABIOGEN PHARMA SPA·Filed 2003·Granted Mar 16, 2010·0 cites·12 claims
- 2729US2020375897A1Composition for calcium supplementationABIOGEN PHARMA SPA·Filed 2018·Application pending·0 cites
- 2826US7132394B2PTH-like peptidesABIOGEN PHARMA SPA·Filed 2005·Granted Nov 7, 2006·0 cites·10 claims
Join the waitlist — get patent alerts
Get an alert when ABIOGEN PHARMA SPA files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →